Our guest is Michael Ruzek, financial planner by day and Powder Buoy by night. Michael predicts snow storms in the Wasatch Back two weeks in advance by watching NOAA Buoy 51101 off the coast of Kauai. Michael has figured out that when the buoy hits a certain swell height a winter’s storm will hit two weeks later 3,000 miles away in Park City. Michael joins John and Bruce to recap the 2018/2019 snowstorm season.

John Wells and guest co-host Bruce Kasanoff Are joined by Elizabeth Cobb who has written and produced : CyberWork and the American Dream, which began airing on PBS stations around the country April 11th. Are robots and artificial intelligence coming for our jobs? The fear that technology will replace humans resulted in the Ottoman Empire banning the printing press; The Pope imprisoned Galileo and Queen Elizabeth prohibited a weaving machine that would put knitters out of work. But when the

Our guest this morning is Forbes publisher and self-proclaimed late bloomer Rich Karlgaard who has written: LATE BLOOMERS: The Power of Patience in a World Obsessed with Early Achievement . Karlgaard traces the development of our misguided assumption that early success is the best or only success. He then draws on several years of research and interviews with neuroscientists, psychologists, and countless people at different stages in their careers to illustrate why late blooming is in fact the

Our guest is Paul Sutter, an astrophysicist and the chief scientist at the COSI (Center for Science and Industry) in Columbus, Ohio. Paul joins to talk about the photo of black hole M87 which was released on April 10. M87 is found within the constellation Virgo and is this image is the historic first image captured of a black hole. Not surprisingly, how this image came into being is complicated and many teams of experts all over the globe worked to capture it.

Dr. Lane Brostrom, CEO of CMXTwenty, a private company, recently opening offices in the Park City area, that is developing a non-narcotic pain therapy to replace opioids. Today, we will talk about the science of pain therapies, particularly opioids, and other drugs like Lyrica, Tylenol, Ibuprofen and how the pharmaceutical science of CMXTwenty is different.

Henry Timms joins the show - he is the co-author of New Power, and he talks about how power works in our hyperconnected world--and how to make it work for you. New Power shines fresh light on the cultural phenomena of our day, from the #MeToo and #BlackLivesMatter movements to the Ice Bucket Challenge to Airbnb. Jeremy Hermans and Henry Timms uncover the new power forces that made them huge.

Today we speak with Richard Lieberman, an award-winning writer who presents a story about genetic engineering and CRISPR technology and the controversy that surrounds it. Lieberman’s book Bad Seed is a novel but it's also a scientific essay on the modification of genes in plants and animals, and now humans.

Cada Domingo talks with Salvador Oregon-Torres, the youth programs organizer with United Communities. We talk with Salvador about his life, including leaving Mexico at 11 months of age, his work with non-profit organizations, and his experiences as a queer person in the United States. Cada Domingo habla con Salvador Oregon-Torres, organizador de Programas Juveniles Comunidades Unidas. Hablamos con Salvador de su vida, incluyendo el dejar a México a los 11 meses de edad, su trabajo con

Joining Cool Science Radio is Dr. Michael Selsted, Chief Science Officer for Oryn Therapeutics. Oryn Therapeutics has products in pre-clinical testing that could have a profound impact on the treatment of autoimmune and inflammatory diseases and life-threatening, drug-resistant infections.

Our guest is Kevin Holden, the head of Synthetic Biology for Synthego, a genome engineering company. Kevin helps us understand: What is CRISPR? How does it work? What are it’s capabilities and what are its shortcomings? What are the ethical questions surrounding this new technology?